1-2 of 2
Mark Bishton, MBChB, MRCP, FRCPath, PhD
Close
Sort by
Journal Articles

Bendamustine Plus Rituximab for the Treatment of Waldenström Macroglobulinaemia: Patient Outcomes and Impact of Bendamustine Dosing

Suzanne O Arulogun, MBBS, Duncan Brian, Harshita Goradia, Aaron Cooney, Tobias Menne, MD PhD, Dipti Talaulikar, PhD FRACP, FRCPA, MBBS, Aideen Therese O'Neill, FRCPath, Josephine M.I Vos, Guy Pratt, FRCPath, Deborah Turner, Kirsty Marshall, Kate Manos, MBBS, Claire Anderson, Maria Gavriatopoulou, Charalampia Kyriakou, MD PhD, Monique C. Minnema, Dima El-Sharkawi, MBBS, FRCPath, PhD, Marie José Kersten, MD PhD, RayMun Koo, Helen McCarthy, PhD FRCPath, Mark Bishton, MBChB, MRCP, FRCPath, PhD, George Follows, Ashutosh D. Wechalekar, Shirley D'Sa, MD FRCPath
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-140774
Published: 2020
Journal Articles

Ibrutinib Plus Venetoclax in Patients With Relapsed/Refractory Mantle Cell Lymphoma: Results From the Safety Run-In Period of the Phase 3 Sympatico Study

Constantine S. Tam, MD, Radhakrishnan Ramchandren, MD, Robert Chen, MD, Lionel Karlin, MD, Geoffrey Chong, MD, Wojciech Jurczak, MD PhD, Ka Lung Wu, MD PhD, Mark Bishton, MBChB, MRCP, FRCPath, PhD, Graham P. Collins, MD DPhil, Paul Eliadis, MBBS, FRACP, FRCPA, Frédéric Peyrade, MD, Edith Szafer-Glusman, PhD, Yihua Lee, PhD, Karl Eckert, BA, Jutta K. Neuenburg, MD PhD, Michael Wang, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–41.
https://doi.org/10.1182/blood-2020-134392
Published: 2020